Morgan Stanley’s Invesco NASDAQ Biotechnology ETF IBBQ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$16K Buy
+551
New +$16K ﹤0.01% 6802
2025
Q3
Sell
-1
Closed -$24 8252
2025
Q2
$24 Sell
1
-3,062
-100% -$62.8K ﹤0.01% 7972
2025
Q1
$64.9K Buy
3,063
+3,061
+153,050% +$68.1K ﹤0.01% 6186
2024
Q4
$47 Buy
+2
New +$46 ﹤0.01% 7622
2024
Q3
Sell
-1
Closed -$34 7975
2024
Q2
$34 Sell
1
-500
-100% -$10.9K ﹤0.01% 7620
2024
Q1
$11.1K Buy
+501
New +$11.1K ﹤0.01% 6665
2023
Q4
Sell
-1,000
Closed -$19.8K 7861
2023
Q3
$19.8K Hold
1,000
﹤0.01% 6493
2023
Q2
$20.4K Hold
1,000
﹤0.01% 6563
2023
Q1
$20.7K Hold
1,000
﹤0.01% 6617
2022
Q4
$21.1K Sell
1,000
-63
-6% -$1.3K ﹤0.01% 6679
2022
Q3
$20K Hold
1,063
﹤0.01% 6793
2022
Q2
$20K Hold
1,063
﹤0.01% 6988
2022
Q1
$22K Sell
1,063
-48,937
-98% -$1.01M ﹤0.01% 7104
2021
Q4
$1.19M Sell
50,000
-300,000
-86% -$7.31M ﹤0.01% 4950
2021
Q3
$8.96M Sell
350,000
-50,000
-13% -$1.32M ﹤0.01% 3029
2021
Q2
$10.4M Buy
+400,000
New +$10.2M ﹤0.01% 2934

Other funds holding IBBQ

Morgan Stanley's IBBQ Position: Q1 2026 in Review

Morgan Stanley opened a new position in Invesco NASDAQ Biotechnology ETF (IBBQ) in Q1 2026: 551 shares worth $16K. The stake represents ﹤0.01% of the portfolio and ranks #6802 among its holdings. This is a return to the name: Morgan Stanley previously reported a position in IBBQ as recently as Q2 2025.

Morgan Stanley first reported a position in IBBQ in Q2 2021 and has held it in 16 quarters since. The position peaked at $10.4M in Q2 2021. 40 funds tracked by Wall St. Rank hold IBBQ as of Q1 2026.

  • Morgan Stanley held 551 shares of Invesco NASDAQ Biotechnology ETF worth $16K as of Q1 2026.
  • Invesco NASDAQ Biotechnology ETF was a new Morgan Stanley position in Q1 2026.
  • Invesco NASDAQ Biotechnology ETF made up ﹤0.01% of Morgan Stanley's portfolio in Q1 2026, its #6802 holding.
  • Morgan Stanley first reported a position in Invesco NASDAQ Biotechnology ETF in Q2 2021 and has held it in 16 quarters since.
  • Morgan Stanley's Invesco NASDAQ Biotechnology ETF position peaked at $10.4M in Q2 2021.
  • 40 funds tracked by Wall St. Rank held Invesco NASDAQ Biotechnology ETF as of Q1 2026.

Based on Morgan Stanley's 13F filing for Q1 2026, filed 15 May 2026.